Related Experiment Video
Updated: May 9, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Metabolic decompensation events among patients with propionic acidemia across the US: A large electronic medical
Vanja Sikirica1, Geetanjoli Banerjee2, Sue Perera2
1Moderna Therapeutics, Inc., Princeton, NJ, United States of America.
Abstract:
Propionic acidemia (PA) is a rare, inherited, metabolic disorder affecting amino acid metabolism. PA is characterized by periods of catabolism, which can lead to metabolic decompensation events (MDEs), commonly defined by metabolic acidosis and/or hyperammonemia. This retrospective study used TriNetX (1/1/2015-4/24/2022), a large longitudinal, electronic medical record database, to describe the clinical profile and burden of MDEs for patients with PA in the United States (US). Patients with known age were indexed on their first observed PA diagnosis on or after January 2015. Rates of MDEs, MDE-related clinical parameters, and healthcare resource utilization (HCRU) were assessed during the follow-up period (from index to death, end of data, or a 183-day gap in encounters). Among 269 patients with PA (55.0% adults, 51.3% male), 79 patients (29.4%) experienced ≥1 MDE in an inpatient (IP) or emergency room (ER) setting, and 128 patients (47.6%) experienced ≥1 MDE in any setting including the ambulatory setting. The rate of IP/ER MDEs was 0.53 per patient-year (PPY; 95% confidence interval: 0.36, 0.78); visually, rates followed a U-shaped distribution being higher in patients aged 0 to <2 years (0.58 PPY) and adults ≥18 years (0.72 PPY) compared to patients aged 2 to 18 years (0.22-0.34 PPY). Adults' MDEs commonly involved metabolic acidosis (86.7%) while pediatrics' MDEs commonly involved hyperammonemia (43.4-55.6%). Infection was the most common MDE trigger (63.3%); vomiting (45.6%) and seizure activity (41.8%) the most common MDE symptoms. A higher proportion of patients with MDEs died (21.5%) than those without MDEs (14.7%) during the entire study period; patients with MDEs also had a higher proportion of comorbidities and treatment usage than those without MDEs. This study provides the largest assessment of patients with PA across the US and documents the substantial morbidity with a focus on MDE burden, as well as mortality, highlighting clear unmet need.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
11:25Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
Related Concept Videos
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...